Relay Therapeutics
RLAY
RLAY
137 hedge funds and large institutions have $2.96B invested in Relay Therapeutics in 2021 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 65 increasing their positions, 26 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more call options, than puts
Call options by funds: $17K | Put options by funds: $17K
2.34% less ownership
Funds ownership: 97.46% → 95.12% (-2.3%)
19% less capital invested
Capital invested by funds: $3.64B → $2.96B (-$685M)
Holders
137
Holding in Top 10
13
Calls
$17K
Puts
$17K
Top Buyers
| 1 | +$80.6M | |
| 2 | +$50M | |
| 3 | +$36.9M | |
| 4 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$27.1M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$25.3M |
Top Sellers
| 1 | -$439M | |
| 2 | -$117M | |
| 3 | -$15M | |
| 4 |
PA
Perceptive Advisors
New York
|
-$10.8M |
| 5 |
AI
Alphabet Inc
Mountain View,
California
|
-$8.05M |